According to a new report by Reports and Data, the global Hospital Acquired Infections (HAI) Diagnostics market is expected to reach USD 5.68 Billion by 2027. The growth of the market is attributed to the increase in the number of HAIs and contagious virus-related diseases, leading to an increase in the demand for surgical operations. Technological advancements and increasing public awareness have also contributed to the growth of the industry.

The immediate need of the time is the rapid diagnosis of infectious diseases due to evolving pathogens and the increasing occurrence rate of hospital-acquired infections. Governments of various nations, including the U.S., have emphasized the rapid diagnosis of infectious diseases as a strategic priority. The COVID-19 pandemic has also contributed to the growing demand for laboratory-based molecular testing capacity and reagents.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/3478

One of the significant challenges faced by the market players during this epidemic is the disruption in supply chain management. When the pandemic reached its peak in China, transportation was halted, resulting in a break in the supply chain. This disruption was not due to the lack of manufacturing but due to the challenge of mobility of goods from one part of the nation to another.

COVID-19 has also resulted in elevated demand for point-of-care immunodiagnostic tests, leading to the development of easy-to-use and rapid devices to support testing outside of laboratory settings. These test kits are developed by manufacturers based either on detection of antibodies caused due to the infection or identification of proteins from the coronavirus in respiratory samples.

Further key findings from the report suggest that disease testing in HAI diagnostic is anticipated to witness a higher growth rate during the forecast period. North America held the largest market share throughout the forecast period, with the presence of a large number of educational institutes, hospitals, corporate buildings, and an increase in self-hygiene among people influencing the growth of the industry.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/3478

Key participants in the market include Abbott Laboratories, Roche AG, bioMérieux, Alere, Inc., Becton Dickenson, Siemens Healthcare, Thermo Fisher Scientific, Cepheid Inc., Qiagen, and Seegene, Inc., among others.

The global Hospital Acquired Infections (HAI) Diagnostics market has been segmented based on product, test type, application, infection type, end-user, and region. The segments include consumables, instruments and reagents, urinalysis, molecular diagnostic, immunoassay, drug resistance testing, disease testing, bloodstream infections, gastrointestinal infections, hospital-acquired pneumonia, surgical site infections, urinary tract infections, clinics, hospitals, ambulatory surgery centers, and others.

In conclusion, the Hospital Acquired Infections (HAI) Diagnostics market is expected to witness significant growth during the forecast period due to the rise in the number of HAIs, contagious virus-related diseases, and technological advancements. However, the disruption in supply chain management may hinder the growth of the market.

 Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/3478

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs